ID   KM1334
AC   CVCL_D3LC
DR   ABCD; ABCD_AQ232
RX   PubMed=9605740;
RX   Patent=US7241568;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5451.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P55075; Human FGF8 (isoform FGF-8B) (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   PubMed=9605740;
RA   Tanaka A., Furuya A., Yamasaki M., Hanai N., Kuriki K., Kamiakito T.,
RA   Kobayashi Y., Yoshida H., Koike M., Fukayama M.;
RT   "High frequency of fibroblast growth factor (FGF) 8 expression in
RT   clinical prostate cancers and breast tissues, immunohistochemically
RT   demonstrated by a newly established neutralizing monoclonal antibody
RT   against FGF 8.";
RL   Cancer Res. 58:2053-2056(1998).
//
RX   Patent=US7241568;
RA   Hanai N., Yamasaki M., Furuya A., Tanaka A., Shitara K., Shimada N.,
RA   Nakamura K., Hirota M.;
RT   "Anti-fibroblast growth factor-8 monoclonal antibody.";
RL   Patent number US7241568, 10-Jul-2007.
//